SG11201403265VA - Medical composition for preventing or treating amyloid β peptide related diseases or conditions - Google Patents
Medical composition for preventing or treating amyloid β peptide related diseases or conditionsInfo
- Publication number
- SG11201403265VA SG11201403265VA SG11201403265VA SG11201403265VA SG11201403265VA SG 11201403265V A SG11201403265V A SG 11201403265VA SG 11201403265V A SG11201403265V A SG 11201403265VA SG 11201403265V A SG11201403265V A SG 11201403265VA SG 11201403265V A SG11201403265V A SG 11201403265VA
- Authority
- SG
- Singapore
- Prior art keywords
- preventing
- conditions
- related diseases
- medical composition
- peptide related
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
- A23G4/10—Chewing gum characterised by the composition containing organic or inorganic compounds characterised by the carbohydrates used, e.g. polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/64—Orobanchaceae (Broom-rape family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Inorganic Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161576367P | 2011-12-16 | 2011-12-16 | |
| PCT/CN2012/086796 WO2013087042A1 (en) | 2011-12-16 | 2012-12-17 | Medical composition for preventing or treating amyloid β peptide related diseases or conditions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201403265VA true SG11201403265VA (en) | 2014-09-26 |
Family
ID=48580733
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201403265VA SG11201403265VA (en) | 2011-12-16 | 2012-12-17 | Medical composition for preventing or treating amyloid β peptide related diseases or conditions |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20150087606A1 (en) |
| EP (1) | EP2792361B1 (en) |
| JP (1) | JP6134331B2 (en) |
| KR (1) | KR102048289B1 (en) |
| CN (1) | CN103156867B (en) |
| AU (1) | AU2012350437B2 (en) |
| CA (1) | CA2859227C (en) |
| MY (1) | MY171048A (en) |
| SG (1) | SG11201403265VA (en) |
| TW (1) | TWI488630B (en) |
| WO (1) | WO2013087042A1 (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015154721A1 (en) * | 2014-04-10 | 2015-10-15 | 杏辉天力（杭州）药业有限公司 | Isoacteoside derivative and preparation method and use thereof |
| TWI650131B (en) * | 2014-07-03 | 2019-02-11 | 杏輝藥品工業股份有限公司 | Cistanche tubulosa extract for the preparation of medicines or foods for the protection of ocular cells |
| CN104922137B (en) * | 2015-06-04 | 2018-07-31 | 苏州大学 | The new application of benzyl carbinol glycoside compound Torenoside B |
| KR102018085B1 (en) * | 2017-12-06 | 2019-09-04 | 김좌진 | Pharmaceutical Composition for Treatment and Inhibiting Metastasis of Brain Tumor Comprising Acteoside |
| KR102135148B1 (en) * | 2019-08-28 | 2020-07-20 | 김좌진 | Pharmaceutical Composition for Treatment and Inhibiting Metastasis of Brain Tumor Comprising Acteoside |
| CN111632058A (en) * | 2020-06-24 | 2020-09-08 | 新疆医科大学 | Application of verbascoside in preparing medicament for preventing and treating neurodegenerative diseases |
| CN112225766A (en) * | 2020-10-27 | 2021-01-15 | 杏辉天力（杭州）药业有限公司 | Method for enriching and separating phenylethanoid glycosides compounds from cistanche deserticola extract |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100500584B1 (en) * | 2002-08-12 | 2005-07-12 | 경희대학교 산학협력단 | Composition comprising the extract of Cistanche deserticola Y.C.MA showing enhancing activity of the neurite outgrowth and neurotrophic effects |
| KR100514076B1 (en) * | 2003-01-10 | 2005-09-13 | 주식회사 엘컴사이언스 | Composition for prevention and treatment of neurodegenerative disease having phenylethanoid derivatives |
| TW200416036A (en) * | 2003-02-18 | 2004-09-01 | Sinphar Pharmaceutical Co Ltd | Medicinal preparation containing phenylethanoid glycosides extracted from herbaceous plant, cistanche tubulosa (schenk.) wight, process of making the same, and uses of the same |
| CN1268341C (en) * | 2003-03-04 | 2006-08-09 | 杏辉天力（杭州）药业有限公司 | Tubiflorous desert cistanche prepn containing phenethyl alcohol glycoside and its prepn process and use |
| CN100345857C (en) * | 2004-07-16 | 2007-10-31 | 北京华医神农医药科技有限公司 | Process for extracting and separating echinacoside from broomrape |
| EP1736167B1 (en) * | 2005-06-20 | 2018-03-21 | I.R.B. Istituto Di Ricerche Biotecnologiche S.r.l. | Extracts obtained from cell line cultures from Syringa vulgaris IRB-SV25/B (DMS:16857), their preparation and use |
| JP5410683B2 (en) * | 2008-02-19 | 2014-02-05 | 学校法人近畿大学 | Hepatoprotective agent and anti-TNF-α agonist obtained from Kankaniku Juyo |
| CN101411753B (en) * | 2008-12-04 | 2012-02-29 | 闫明 | Use of broomrape glycosides in preparing medicine for treating senile dementia |
| CN101797307B (en) * | 2010-04-09 | 2011-08-10 | 广州中医药大学 | Phenethyl alcohol glycoside-containing callicarpa kochiana extractive and preparation method thereof |
| TWI486162B (en) * | 2010-06-16 | 2015-06-01 | Sinphar Pharmaceutical Co Ltd | Use of isoacteoside or pharmaceutically acceptable salt thereof in inhibiting formation, accumulation or aggregation of amyloid beta peptides, and in fabrication of drug for preventing or treating amyloid beta peptide-associated diseases or conditions |
| CN102670631B (en) * | 2011-12-01 | 2013-07-31 | 河南科技大学 | Olive total phenylethanoid glycoside composition and preparation and application thereof |
-
2012
- 2012-12-17 CA CA2859227A patent/CA2859227C/en active Active
- 2012-12-17 KR KR1020147018051A patent/KR102048289B1/en active IP Right Grant
- 2012-12-17 US US14/365,404 patent/US20150087606A1/en not_active Abandoned
- 2012-12-17 SG SG11201403265VA patent/SG11201403265VA/en unknown
- 2012-12-17 MY MYPI2014001777A patent/MY171048A/en unknown
- 2012-12-17 CN CN201210548516.0A patent/CN103156867B/en active Active
- 2012-12-17 AU AU2012350437A patent/AU2012350437B2/en active Active
- 2012-12-17 EP EP12856624.7A patent/EP2792361B1/en active Active
- 2012-12-17 TW TW101147781A patent/TWI488630B/en active
- 2012-12-17 WO PCT/CN2012/086796 patent/WO2013087042A1/en active Application Filing
- 2012-12-17 JP JP2014546303A patent/JP6134331B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| KR20150002576A (en) | 2015-01-07 |
| EP2792361A1 (en) | 2014-10-22 |
| TW201325597A (en) | 2013-07-01 |
| JP6134331B2 (en) | 2017-05-24 |
| CA2859227C (en) | 2019-01-22 |
| US20150087606A1 (en) | 2015-03-26 |
| JP2015500300A (en) | 2015-01-05 |
| EP2792361B1 (en) | 2019-03-27 |
| CA2859227A1 (en) | 2013-06-20 |
| AU2012350437B2 (en) | 2017-06-29 |
| EP2792361A4 (en) | 2015-05-13 |
| CN103156867A (en) | 2013-06-19 |
| WO2013087042A1 (en) | 2013-06-20 |
| TWI488630B (en) | 2015-06-21 |
| MY171048A (en) | 2019-09-23 |
| AU2012350437A1 (en) | 2014-07-31 |
| CN103156867B (en) | 2019-04-30 |
| KR102048289B1 (en) | 2020-01-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20190491T1 (en) | 1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases | |
| ZA201207613B (en) | Novel compounds for the treatment of diseases associated with amyloid or amyloid-like proteins | |
| PL2643004T3 (en) | Oligosaccharide composition for treating skin diseases | |
| EP2872151A4 (en) | Acellular pro-tolerogenic compositions for the treatment/prevention of auto-immune diseases | |
| EP2432476A4 (en) | Methods for treating or preventing ophthalmological diseases | |
| HK1198012A1 (en) | Composition for the treatment of fistula | |
| GB201021103D0 (en) | New compounds for the treatment of neurodegenerative diseases | |
| SG11201403265VA (en) | Medical composition for preventing or treating amyloid β peptide related diseases or conditions | |
| EP2906583A4 (en) | Peptides for the treatment of neurodegenerative diseases | |
| HK1204452A1 (en) | Treatment for bone diseases | |
| BR112014004416A2 (en) | compositions and methods for the treatment of neurodegenerative diseases | |
| EP2694465A4 (en) | Ortho-fluoro substituted compounds for the treatment of metabolic diseases | |
| IL241253A0 (en) | Peptides for the treatment of neurodegenerative diseases | |
| HK1183807A1 (en) | Composition for treating neurodegenerative disease or neuropathological condition | |
| EP2604264A4 (en) | Pharmaceutical composition for treating viral diseases | |
| EP2536436A4 (en) | Antimir-451 for the treatment of polycythemias | |
| HUP1100290A2 (en) | Combination compositions for the treatment of proliferative diseases | |
| IL234796B (en) | Compounds for the treatment of ischemia-reperfusion-related diseases | |
| EP2785342A4 (en) | Pharmaceutical composition for preventing or treating hypertriglyceridemia or hypertriglyceridemia-associated diseases | |
| HUP1100245A2 (en) | Pharmaceutical composition for the treatment of wounds | |
| HK1157189A1 (en) | Pharmaceutical composition for the treatment of tumor diseases | |
| GB201110659D0 (en) | composition for skin treatment | |
| GB201110653D0 (en) | Composition for skin treatment | |
| AU2012901596A0 (en) | A Pharmaceutical Composition and Method for Treating or Preventing Beta Amyloid Diseases | |
| AU2012901597A0 (en) | A Pharmaceutical Composition and Method for Treating or Preventing Beta Amyloid Diseases |